image
Veracyte, Inc. VCYT
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 35.94
-2.97 %
$ 2.79 B
Market Cap
-276.46
P/E
BALANCE SHEET
1.11 B ASSETS
-3.59%
Growth Rates
1Year -3.59%
3Years 34.60%
5Years 56.01%
7Years 40.92%
10Years 30.20%
70.8 M LIABILITIES
-12.83%
Growth Rates
1Year -12.83%
3Years 25.37%
5Years 11.61%
7Years 7.95%
10Years 11.81%
1.04 B EQUITY
-2.89%
Growth Rates
1Year -2.89%
3Years 35.33%
5Years 67.26%
7Years 50.54%
10Years 33.88%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Veracyte, Inc.
image
Current Assets 286 M
Cash & Short-Term Investments 216 M
Receivables 40.4 M
Other Current Assets 28.8 M
Non-Current Assets 829 M
Long-Term Investments 0
PP&E 30.9 M
Other Non-Current Assets 798 M
Current Liabilities 61.2 M
Accounts Payable 12.9 M
Short-Term Debt 10.2 M
Other Current Liabilities 38.1 M
Non-Current Liabilities 9.56 M
Long-Term Debt 7.52 M
Other Non-Current Liabilities 2.04 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011
ASSETS
Cash & Cash Equivalents 216.5 154.2 173.2 349.4 159.3 78.0 33.9 59.2 39.1 35.0 71.2 14.0 7.6
Short Term Investments 0 24.6 4.0 0 0 0 0 0 0 0 0 0 0
Receivables 40.4 44.0 41.5 18.5 19.3 13.2 12.7 8.8 3.5 3.0 1.1 0.6 0.2
Inventory 16.1 14.3 11.2 4.7 6.8 3.4 5.3 3.5 3.8 3.7 2.6 1.1 0.3
Other Current Assets 12.7 11.5 17.2 3.2 2.2 2.4 4.0 2.2 1.6 1.6 3.0 0.8 0.5
Total Current Assets 285.6 248.6 243.1 375.7 187.7 97.0 53.9 73.6 47.9 43.3 76.4 16.4 8.6
PP&E 30.9 30.9 31.1 16.8 17.7 8.9 9.7 11.5 10.3 4.2 3.0 2.4 1.7
Intangible Assets 88.6 174.9 202.7 59.9 65.0 12.0 13.1 14.1 15.2 16.0 0.3 0.2 0
Goodwill 703.0 695.9 707.9 2.7 2.7 1.1 1.1 1.1 1.1 1.1 0 0 0
Long Term Investments 0 0.7 0.7 0.6 0.6 0.6 0.6 0.6 0.6 (0.3) 0 0 0
Other Long Term Assets 6.8 (26.8) (35.1) 2.0 2.0 1.7 0.9 0.7 0.8 0.3 16 K 56 K 0.2
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 1 114.9 1 156.4 1 187.8 457.2 275.2 120.6 78.7 101.0 75.3 64.8 79.6 19.1 10.5
LIABILITIES
Accounts Payable 12.9 11.9 12.4 3.1 2.3 2.5 3.9 2.4 5.1 7.4 5.3 1.9 0.6
Short Term Debt 10.2 8.1 8.4 3.2 2.8 1.4 0 0 0 0 0 0 0
Other Current Liabilities 36.1 40.0 38.8 10.1 12.3 9.2 8.2 9.1 9.6 9.7 10.1 7.1 1.3
Total Current Liabilities 61.2 62.6 64.2 16.8 17.5 13.1 12.0 11.5 14.7 17.1 15.4 9.0 1.9
Long Term Debt 7.5 10.6 14.1 10.7 12.2 23.9 25.2 25.5 5.0 4.9 4.9 0 0
Deferred Tax Income 0.7 4.5 5.6 0 0 0 0 0 0 0.3 0 0 0
Other Liabilities 1.3 3.4 7.1 7.6 6.1 3.9 4.2 4.4 4.3 1.1 2.9 5.2 0
Total Liabilities 70.8 81.2 91.3 35.9 35.8 40.9 41.4 41.5 24.0 23.5 23.2 14.2 1.9
EQUITY
Common Stock 73 K 72 K 71 K 58 K 50 K 41 K 34 K 34 K 28 K 23 K 21 K 1 K 1 K
Retained Earnings (468.1) (393.7) (357.2) (281.6) (246.7) (234.1) (211.1) (180.1) (148.7) (115.0) 56.4 (60.1) (41.4)
Other Accumulative Comprehensive Income/Loss (24.0) (31.3) (15.1) 0 0 (12.0) (9.3) (6.8) (5.4) (4.0) (2.8) (1.8) (1.1)
Total Equity 1 044.1 1 075.2 1 096.5 421.2 239.5 79.8 37.2 59.6 51.3 41.4 56.4 4.9 8.5
Total Liabilities and Equity 1 114.9 1 156.4 1 187.8 457.2 275.2 120.6 78.7 101.0 75.3 64.8 79.6 19.1 10.5
SHARES OUTSTANDING
Common Shares Outstanding 72.6 71.5 67.9 53.2 46.1 37.0 33.9 28.8 25.9 21.6 4.2 14.2 14.2